WallStSmart
CYCN

Cyclerion Therapeutics Inc

NASDAQ: CYCN · HEALTHCARE · BIOTECHNOLOGY

$3.31
-0.30% today

Updated 2026-04-30

Market cap
$12.73M
P/E ratio
P/S ratio
6.14x
EPS (TTM)
$-1.11
Dividend yield
52W range
$1 – $8
Volume
5.6M

WallStSmart proprietary scores

21
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$8.00
+141.69%
12-Month target
Intrinsic (DCF)
$5.04
Margin of safety
+75.79%

Price chart

X-Ray snapshot

Strengths
+ 75.79% below intrinsic value
Risks
- Thin margins at -170.10%
- Negative free cash flow $-1.58M
- Revenue declining -43.20% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$297000.00$0.00$2.00M$2.07M$2.07M
Net income$-44.08M$-5.26M$-3.06M$-3.53M$-799000.00
EPS$-1.11
Free cash flow$-40.61M$-21.25M$-4.33M$-3.31M$-1.58M
Profit margin-14,841.08%-152.85%-170.11%-170.10%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CYCN$12.73M215.32.06.75.0+75.79%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Cyclerion Therapeutics Inc trades at $3.31. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $2.07M. with profit margins at -170.10%. Our DCF model estimates intrinsic value at $5.04.

Frequently asked questions

What is Cyclerion Therapeutics Inc's stock price?
Cyclerion Therapeutics Inc (CYCN) trades at $3.31.
Is Cyclerion Therapeutics Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell). DCF value $5.04.
What is the price target of Cyclerion Therapeutics Inc (CYCN)?
The analyst target price is $8.00, representing +141.7% upside from the current price of $3.31.
What is the intrinsic value of Cyclerion Therapeutics Inc (CYCN)?
Based on our DCF model, intrinsic value is $5.04, a +75.8% margin of safety versus $3.31.
What is Cyclerion Therapeutics Inc's revenue?
TTM revenue is $2.07M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio6.14x
ROE-39.30%
Beta0.89
50D MA$2.12
200D MA$2.07
Shares out0.00B
Float0.00B
Short ratio
Avg volume5.6M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years